HCA 📈 HCA Holdings - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US40412C1018
HCA: Hospitals, Outpatient Centers, Surgical Centers, Emergency Care, Behavioral Hospitals
HCA Healthcare, Inc. is a prominent player in the US healthcare landscape, operating a vast network of hospitals and related healthcare entities across the country. Through its subsidiaries, the company provides a comprehensive range of medical services, including general and acute care, surgical services, and various outpatient services. Its hospitals offer specialized care units, such as intensive care, cardiac care, and diagnostic services, as well as emergency services, catering to the diverse needs of patients. Furthermore, the company's outpatient services encompass a broad spectrum of treatments, including outpatient surgery, laboratory tests, radiology, respiratory therapy, cardiology, and physical therapy, ensuring that patients receive timely and effective care.
In addition to its hospital network, HCA Healthcare, Inc. operates a significant number of outpatient healthcare facilities, comprising freestanding ambulatory surgery centers, emergency care facilities, urgent care centers, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, and radiation and oncology therapy centers. These facilities are strategically located to provide convenient access to healthcare services for patients in various communities. The company also operates a range of physician practices, further expanding its reach and capabilities in the healthcare sector. Moreover, its behavioral hospitals offer specialized therapeutic programs, including psychiatric care, substance abuse treatment, and counseling services, addressing the complex needs of patients with mental health and addiction issues.
With a history dating back to 1968, HCA Healthcare, Inc. has established itself as a leading healthcare provider in the United States. Headquartered in Nashville, Tennessee, the company has evolved over the years, adapting to the changing healthcare landscape and expanding its services to meet the growing needs of patients. As a publicly traded company, HCA Healthcare, Inc. is committed to delivering high-quality care while maintaining a strong financial foundation. Its common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol HCA, and the company is classified under the GICS Sub Industry: Health Care Facilities, reflecting its focus on operating healthcare facilities and providing related services.
Additional Sources for HCA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HCA Stock Overview
Market Cap in USD | 80,675m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2011-03-10 |
HCA Stock Ratings
Growth 5y | 77.2% |
Fundamental | 51.3% |
Dividend | 46.1% |
Rel. Strength Industry | 214 |
Analysts | 4.2/5 |
Fair Price Momentum | 291.76 USD |
Fair Price DCF | 600.58 USD |
HCA Dividends
Dividend Yield 12m | 0.87% |
Yield on Cost 5y | 1.85% |
Annual Growth 5y | 8.45% |
Payout Consistency | 49.9% |
HCA Growth Ratios
Growth Correlation 3m | -93.1% |
Growth Correlation 12m | 67.3% |
Growth Correlation 5y | 91% |
CAGR 5y | 16.25% |
CAGR/Mean DD 5y | 1.54 |
Sharpe Ratio 12m | 0.45 |
Alpha | -21.22 |
Beta | 1.40 |
Volatility | 29.46% |
Current Volume | 2933k |
Average Volume 20d | 1503.7k |
As of December 21, 2024, the stock is trading at USD 303.62 with a total of 2,932,996 shares traded.
Over the past week, the price has changed by -3.28%, over one month by -8.63%, over three months by -24.81% and over the past year by +16.14%.
Partly, yes. Based on ValueRay Fundamental Analyses, HCA Holdings (NYSE:HCA) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 51.27 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HCA as of December 2024 is 291.76. This means that HCA is currently overvalued and has a potential downside of -3.91%.
HCA Holdings has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy HCA.
- Strong Buy: 15
- Buy: 3
- Hold: 5
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, HCA HCA Holdings will be worth about 319.9 in December 2025. The stock is currently trading at 303.62. This means that the stock has a potential upside of +5.38%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 404.2 | 33.1% |
Analysts Target Price | 315.6 | 3.9% |
ValueRay Target Price | 319.9 | 5.4% |